Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump

Journal of Clinical Gastroenterology

Volumn 40, Issue 2, 2006, Pages 171-175

  Kubitz, Ralf ^a   Keitel, Verena ^a   Scheuring, Sybille ^a   Köhrer, Karl ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bile secretion; Cholemia; Jaundice; Mutation; Posttranscriptional regulation

Indexed keywords

ALANINE; ANTIBODY; BILE SALT; BILE SALT EXPORT PUMP; GLUTAMIC ACID; GLYCINE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VALINE; ABC TRANSPORTER; ABCB11 PROTEIN, HUMAN; BILE ACID;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; BILE FLOW; BSEP GENE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; LABORATORY TEST; LIVER CELL MEMBRANE; MALE; NUCLEOTIDE SEQUENCE; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN STABILITY; RECURRENT DISEASE; TRANSCRIPTION REGULATION; BIOPSY; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; ION TRANSPORT; METABOLISM; MUTATION; PATHOLOGY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BIOPSY; CHOLESTASIS, INTRAHEPATIC; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; ION PUMPS; MALE; MUTATION; PHENOTYPE; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33645803240     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000196406.15110.60     Document Type: Article

References (36)

1. Kircheis G, Wettstein M, Timmermann L, et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357-366.
2. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology. 1997;113:995-999.
3. Kadakol A, Ghosh SS, Sappal BS, et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16:297-306.
4. Bull LN, van Eijk MJ, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet. 1998;18:219-224.
5. van Mil SW, Van Der Woerd WL, Van Der BG, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology. 2004;127:379-384.
6. Saito S, Iida A, Sekine A, et al. Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47:38-50.
7. Pauli-Magnus C, Kerb R, Fattinger K, et al. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 2004;39:779-791.
8. Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics. 2004;14:91-102.
9. Keitel V, Burdelski M, Warskulat U, et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology. 2005;41:1160-1172.
10. Eisenberg E, Levanon EY. Human housekeeping genes are compact. Trends Genet. 2003;19:362-365.
11. Kubitz R, Sütfels G, Kühlkamp T, et al. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP Kinase. Gastroenterology. 2004;126:541-553.
12. Noe J, Stieger B, Meier PJ. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology. 2002;123:1659-1666.
13. van Mil SW, Klomp LW, Bull LN, et al. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis. 2001;21:535-544.
14. Rotthauwe HW, Beseler WD, Kowalewski S. Benign recurrent intrahepatic cholestasis. Klin Wochenschr. 1969;47:140-149.
15. Whitington PF, Freese DK, Alonso EM, et al. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 1994;18:134-141.
16. De Koning TJ, Sandkuijl LA, De Schryver JE, et al. Autosomal-recessive inheritance of benign recurrent intrahepatic cholestasis. Am J Med Genet. 1995;57:479-482.
17. Summerskill WH, Walshe JM. Benign recurrent intrahepatic 'obstructive' jaundice. Lancet. 1959;2:686-690.
18. Ujhazy P, Ortiz D, Misra S, et al. Familial intrahepatic cholestasis: 1. Studies of localization and function. Hepatology. 2001;34:768-775.
19. Alvarez L, Jara P, Sanchez-Sabate E, et al. Reduced hepatic expression of Farnesoid X Receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum Mol Genet. 2004;13:2451-2460.
20. Chen F, Ananthanarayanan M, Emre S, et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology. 2004;126:756-764.
21. Strautnieks SS, Kagalwalla AF, Tanner MS, et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet. 1997;61:630-633.
22. Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology. 1997;26:155-164.
23. Jansen PL, Strautnieks SS, Jacquemin E, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology. 1999;117:1370-1379.
24. Strautnieks SS, Bull LN, Knisely AS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998;20:233-238.
25. Chen HL, Chang PS, Hsu HC, et al. FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma- glutamyltranspeptidase levels. J Pediatr. 2002;140:119-124.
26. Meier Y, Stieger B, Moore LB, et al. Hepatocellular malignancy in ABCB11/BSEP disease (Progressive familial intrahepatic cholestasis, type 2): four patients. Hepatology. 2004;40(suppl 1):471A.
27. Ananthanarayanan M, Balasubramanian N, Makishima M, et al. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem. 2001;276:28857-28865.
28. Wang L, Soroka CJ, Boyer JL. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. J Clin Invest. 2002;110:965-972.
29. Plass JR, Mol O, Heegsma J, et al. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump. J Hepatol. 2004;40:24-30.
30. Kubitz R, Saha N, Kühlkamp T, et al. Ca2+dependent protein kinase C isoforms induce cholestasis in rat liver. J Biol Chem. 2004;279:10323-10330.
31. Crocenzi FA, Mottino AD, Cao J, et al. Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats. Am J Physiol Gastrointest Liver Physiol. 2003;285:G449-G459.
32. Hayashi H, Takada T, Suzuki H, et al. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11. Hepatology. 2005;41:916-924.
33. Bijleveld CM, Vonk RJ, Kuipers F, et al. Benign recurrent intrahepatic cholestasis: altered bile acid metabolism. Gastroenterology. 1989;97:427-432.
34. de Pagter AG, Berge Henegouwen GP, Bokkel Huinink JA, et al. Familial benign recurrent intrahepatic cholestasis: interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives? Gastroenterology. 1976;71:202-207.
35. Winter J, Jakob U. Beyond transcription: new mechanisms for the regulation of molecular chaperones. Crit Rev Biochem Mol Biol. 2004;39:297-317.
36. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005;569:29-63.